Analyst Ratings for OncoSec Medical (ONCS) [Neutrals]

ONCS Rating Summary

ONCS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ONCS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $10.67 (+217.5%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 85%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/7/2018 H.C. Wainwright Raghuram Selvaraju Downgrade Neutral
(Buy)
1.00
(4.00)
0.87
(3.36)
286.21% Details